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Abstract 
Advanced cancer patients with cachexia and their families can suffer from eating-related distress. This 
complex entity encompasses patients’ struggle to nourish themselves, emotional and social consequences 
of their inability to maintain food intake, and profound disturbance in family relationships. With evidence-
based nutritional care, as well as symptom management to enable food intake, cachexia can be mitigated to 
some degree. In addition, patients and families require psychosocial support and education to understand 
and cope with this condition. Only by taking an integrated approach can health care teams alleviate eating-
related distress, improve quality of life (QOL), reduce interpersonal conflicts, and alter perceptions of 
nutritional neglect for patients and families. However, few studies have investigated eating-related 
distress among patients and families. The aim of this narrative review is to describe what is known about 
eating-related distress and the roles of integrated palliative, supportive, and nutritional care in improving 
QOL of patients and families. 
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1. Introduction 
Cachexia is particularly prevalent in patients with cancer of advanced stage and has been linked to 
deteriorations in quality of life (QOL), performance status, treatment outcomes, and survival [1-9]. 
Cancer cachexia is defined as a syndrome of body weight loss driven by “a variable combination of reduced 
food intake and altered metabolism” [1, 2]. Reduced food intake is an important and, in some cases, 
dominant driver of this body weight loss. A diminished central drive to eat (anorexia) is pervasive, and 
additionally accompanied by an obstacle course of symptoms that impede food intake (Table 1A). Owing 
to the importance of reduced food intake, cachexia is classified as a form of (disease-associated) 
malnutrition and is considered to be partially mitigated by nutritional support [1-4, 6, 8, 9]. 
 
Patients with cachexia and their family members may suffer from profound psychosocial distress. Prior 
qualitative research have identified eating-related distress as a significant contributor to overall 
psychosocial distress [10-17]. Eating-related distress encompasses a myriad of intersecting factors 
including patients’ and family members’ struggles to cope with cachexia, gross impairment of food intake, 
disturbance of relationships, and changing roles (Table 1A) [10-22]. The current management of cancer 
cachexia is primarily focused on pain and symptom management, nutrition in erventions, as well as, 
development of novel drugs with appetite-enhancing actions. However, to adequately address eating-related 
distress, future clinical practice guidelines must consider holistic, multimodal care including education and 
psychosocial support (Table 1B, Figure 1) [10-22]. 
 
Few studies have investigated eating-related distress among patients and family members; furthermore, the 
segmentation of palliative, supportive, and nutritional care s rvices complicates the matter [10-22]. 
Therefore, the aim of this narrative review is to describe eating-related distress and the roles of integrated 
palliative, supportive, and nutritional care in improving QOL of patients and family members. In particular, 
we will focus on nutrition impact symptoms, perceived need for nutritional support, and conflicts over food 
among patients and family members in palliative and supportive care settings. 
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Table 1. Integration of palliative, supportive, and nutritional care for eating-related distress 
A. Problem: Eating-related distress in patients and family members 
Nutrition impact symptoms impairing food intake [21-25, 28-32] 
• Unpredictable occurrence and course 
• Lack of appetite, early satiety, fatigue, pain, shortness of breath, nausea, vomiting, constipation, diarrhea, abnormal 
taste, abnormal smell, dry mouth, difficulty swallowing, dental problems, drowsiness, anxiety, depression 
• Physical and psychosocial consequences: body weight loss, altered body image, impaired activities of daily living, 
reduced well-being 
Unsuccessful coping strategies of patients and/or family members [10-22, 34 37]
• “Fighting back” against the cancer cachexia 
• Gaps between reality and expectation 
• Shortage of correct information about cancer cachexia and nutrition  
• Insufficient nutritional support by health care teams 
• Feelings of loss of control, helplessness, frustration 
Conflicts over food between patients and family members [10-22, 34-37] 
• Changes in both patients' food preferences and eating habits of whole families 
• Challenges to spousal and family roles and traditions 
• Family members' pressure on patients to eat 
• Differences in beliefs and perceptions between patients and family members 
B. Solution: Integration of palliative, supportive, and nutritional care (Figure 1) 
Manage nutrition impact symptoms [21-25, 28-32, 39] 
Provide psychosocial support for coping of patients and family members [10-22, 34-37] 
Provide nutritional support according to evidence-based clinical practice guidelines [1, 2, 4, 6, 8, 9, 46, 47] 
Provide evidence-based information and advice on nutritional care for patients by famil  members [10-22, 34-37] 
Educate patients and family members about cancer cachexia [10-22, 34-37] 
Initiate end-of-life discussion with patients and family members [13, 37] 
C. Outcome: Effectiveness of integration of palliative, supportive, and nutritional care 
Alleviating eating-related distress of patients and family members [18-22] 
Improving quality of life in patients and family members [18-22] 
Mitigating conflicts between patients and family members [18-22] 
Promoting advanced care planning among patients and family members [13, 37] 
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Figure 1. Integrated model of palliative, supportive, and nutritional care for eating-related distress 
Adequate management of nutrition impact symptoms, i.e., cancer-associated symptoms as well as side 
effects of cancer treatments, is essential to enable food intake. Psychosocial and nutritional support, 
provision of evidence-based information and advice, and education enable patients and family members to 
cope and alleviate eating-related distress. In addition, end-of-life discussion also contributes to optimizing 
coping strategies and advanced care planning. Interdisciplinary cooperation among oncologists, palliative 
care physicians, nurses, dietitians, and others is needed to provide the integrated palliative, supportive, and 
nutritional care. 
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2. Problems 
2.1. Nutrition impact symptoms 
Individuals with incurable cancers experience a diverse and complex burden of symptoms. Many of these 
are deemed nutrition impact symptoms, because they compromise food intake and in turn drive body weight 
loss (Table 1A). However, a consensus on the definition of nutrition impact symptoms in cancer patients 
does not exist. These symptoms may be owing to the cancer itself, cancer treatment, or co-morbidities [23, 
24]. Although lack of a central drive to eat (anorexia) is among the most pervasive of cancer-associated 
symptoms [7, 25], many others are implicated in impaired food intake. Other symptoms implicated include 
early satiety, fatigue, pain, shortness of breath, nausea, vomiting, constipation, diarrhea, abnormal taste and 
smell, dry mouth, difficulty swallowing, dental problems, anxiety, depression, and drowsiness. Due to the 
complex symptom burden of advanced cancer, medical management of pain and symptoms is considered a 
principle component of cancer cachexia management [4, 6].  
 
An important aspect of cancer cachexia management is the identification and evaluation of symptoms 
interfering with food intake. The Edmonton Symptom Assessment System-revised (ESAS-r) [26] and 
Patient-Generated Subjective Global Assessments (PG-SGA) [27] are widely used for symptom assessment, 
some of their components pertain specifically to reduced food intake [21]. While the ESAS-r is able to 
assess the severity of symptoms such as lack of appetite and nausea, other symptoms impeding food intake, 
such as early satiety and diarrhea, are not included. On the other hand, although the PG-SGA is a validated 
tool that can identify several nutrition impact symptoms, the binary outputs (yes/no) do not allow for 
assessment of symptom severity [28]. A comprehensive nutrition impact symptom tool specific to cancers 
of the head and neck has been developed [29], but this has not been validated in other cancer sites. Other 
tools used to capture reduced food intake include food/fluid records and Visual Analogue Scales [25], 
however, the nutritional impact symptoms are not captured by these tools. Given the weaknesses of the 
aforementioned assessment tools, further investigation is needed to develop a comprehensive tool that 
captures the both the breadth and severity of nutrition impact symptoms. Only then, can the association 
between impaired food intake and nutrition impact symptoms be adequately explored.  
 
Despite the limitations described above, several previous studies have attempted to characterize symptom 
profiles of patients with advanced cancer. A study conducted at a cancer cachexia clinic indicated that most 
patients who experienced body weight loss had three or more uncontrolled symptoms. The most common 
symptoms were early satiety (62%), constipation (52%), nausea or vomiting (44%), and mood changes 
(42%) [30]. A study in a nutrition fatigue clinic reported that the five most frequent symptoms were 
abnormal taste and smell (27%), constipation (19%), abdominal pain (14%), difficulty swallowing (12%), 
and epigastric pain (10%) [31]. A large, European cohort study of patients from palliative care in- and out-
patient units, hospices, and general oncology wards compared 9 symptoms of the ESAS-r between a non-
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cachexia group and the cachexia group, categorized using cachexia criteria from the international consensus 
[2, 32]. Their analysis revealed that the frequency of 6 symptoms, i.e., lack of appetite, fatigue, pain, nausea, 
drowsiness, and reduced well-being, were significantly higher in the cachexia group [32]. Finally, a survey 
of advanced cancer patients in palliative and supportive care settings demonstrated that the severity of 16 
symptoms, i.e., 9 symptoms of the ESAS-r and 7 of the PG-SGA, were rated moderate in severity with the 
top 3 being reduced well-being, lack of appetite, and fatigue. The severity of 8 symptoms, i.e., lack of 
appetite, early satiety, fatigue, diarrhea, abnormal taste, difficulty swallowing, drowsiness, and reduced 
well-being, were significantly greater in the cachexia group than in the non-cachexia group based on 
cachexia criteria from the international consensus [2, 21]. In summary, due to the heterogeneity in the 
patient populations, study settings, and assessment tools used in the studies above, direct comparison of the 
severity and frequency of nutrition impact symptoms would be challenging. Thus, development of a 
comprehensive assessment tool is urgently needed to identify and evaluate nutrition impact symptoms in 
palliative and supportive care settings. 
 
2.2. Eating-related distress and perceived need for nutritional support in patients 
Eating-related distress experienced by the patient has been substantially informed by qualitative studies 
involving in depth interviews [10, 13, 14, 16], and this body of work has been systematically reviewed [11, 
12, 15, 17]. Some questionnaires have been devised based on this information, however these requir  
validation [21]. Patients experience many distressing symptoms that reduce food enjoyment and make 
eating unpleasant. Indeed, lack of appetite, reduced food intake, and ongoing body weight loss could lead 
patients to feel that their survival is threatened [10-22]. Nevertheless, patients often become resolute in their 
desire to maintain adequate food intake, forcing themselves to eat despite pain, nausea, and other symptoms. 
An ensuing challenge is the continued body weight loss in spite of varied efforts to maintain intake [1-4, 6, 
8, 9]. The unsuccessful attempts by patients to increase their body weight widens the gap between reality 
and expectation resulting in escalation of patient distress [11-13]. This phenomenon is called the “Calman 
gap” [33], and it can escalate or de-escalate depending on patient’s knowledge of cancer cachexia and 
individual coping strategies [12]. For example, in a small survey of advanced cancer patients in a palliative 
care unit, the four most frequent eating-related distress items belonged to “coping strategies”. It also 
suggested that patients had strong concerns over “lack of appetite”, “inability to eat”, and “body weight 
loss” and that “hopelessness”, “fretting”, and shortage of “correct information” aggravated their distress 
[18]. Another potential exacerbating factor of eating-related distress may be the inability to halt the body 
weight loss, as surveys suggest that patients with cachexia had significantly greater eating-related distress 
than those without cachexia [21].  
 
Lack of credible, proven strategies to manage body weight loss and impaired food intake is a concern 
expressed by patients [18, 20, 21]. In a survey conducted in an inpatient palliative care unit, 76% of patients 
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felt that they had unmet needs that could have been addressed by unit staff, e.g., physicians, nurses, and 
dietitians, with specific knowledge of nutritional support for cancer cachexia [18]. A survey in palliative 
and supportive care settings suggested that patients with advanced cancer wished to rec ive support from a 
health care teams, including nutritional counselling (94%), ideas to improve food intake (88%), and oral 
nutritional supplements (83%). In the case that they became unable to take sufficient nourishment orally, 
patients expressed needs forparenteral nutrition and hydration (77%), and tube feeding (23%) [20].
Expressed needs for these forms of nutritional support were higher in patients with cachexia versus the non-
cachexia group. Of note, tube feeding was regarded as generally undesirable, and almost all respondents to 
a survey did not wish to receive tube feeding even if they could not eat enough [20]. Finally, it has been 
shown that patient-perceived need for nutritional counselling is significantly associated with reduced QOL 
and eating-related distress, particularly in regard to “conflicts over food “, “concerns about food”, and “self-
motivated effect related to nutrition” [22]. 
 
In conclusion, when patient attempts to combat cachexia, many are disappointed with gaps between reality 
and expectation. This disappointment can be intensified by a shortage of correct information, lack of 
provision of nutrition intervention by health care teams, poor coping strategies, and unmet need for 
nutritional support (Table 1A). Unmet, perceived need for nutritional support is significantly associated 
with cachexia and increased eating-related-distress and contributes to reduced QOL.  
 
2.3. Eating-related distress and perceived need for nutritional support in family members 
Eating-related distress experienced by family members has been studied by interview-based qualitative 
approaches [10-17], and also by questionnaires-based quantitative approaches [19, 21]. It is known through 
previous studies that family members suffer when negative impact of cachexia becomes apparent in the 
patient [10-17, 19, 21]. A systematic review of qualitative studies reported 5 particular themes expressed 
by family members of advanced cancer patients: “impact on everyday life”, “taking charge”, “need for 
outside help”, “conflict with patient”, and “emotions” [17]. Additional topics that arose from previous 
studies included the role of female caregivers, sub-processes of “fighting back”, caregiver depression, and 
association between eating-related distress and progressive cachexia. A unique mixed methods study of 
male patients and their female partners also suggested that female caregivers may express fe lings of deep 
concern, frustration, and insufficiency, as well as, making innovative efforts to prepare appealing food [10]. 
The sub-processes: “fighting back”, “letting nature take its course”, or “waffling” have been explored 
through previous qualitative studies [34-36], and further characterized in the most recent quantitative study 
[19, 21]. Specifically, in a 2016 survey of 702 bereaved family members of patients who had received care 
in palliative care units, the five most common items relating to eating-related distress were all categorized 
as “fighting back”, and the sixth item was classified as “letting nature take its course” [19]. The authors 
offered the following four domains for how the “fighting back” sub-process can cause eating-related 
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distress of family members: (factor 1) “feeling that family members forced the patient to eat to avoid death”, 
(factor 2) “feeling that family members made great efforts to help the patient eat”, (factor 3) “feeling that 
eating was a cause of conflict between the patient and family members”, and (factor 4) “feeling that correct 
information was insufficient”. Next, the authors also identified being a patient’s spouse, fair/poor mental 
status, factor 1, and factor 4 as independent prognostic factors of major depression in bereaved family 
members. Insufficient care for eating-related distress among family members, especially spouses with 
weakened mental status, might be associated with major depression among family members after the 
patient’s death [19]. Finally, a 2018 survey in palliative and supportive care settings suggested that family 
members of patients in a cachexia subgroup had significantly greater eating-related distress than those in 
the non-cachexia group. Additionally, the results of this study seem to show that cancer cachexia is more 
distressing for family members than for patients in some items, such as those relating to information about 
the patient’s diet. The questionnaire used in this study has not yet been validated [21]. 
 
Similar to patients, family members also express concerns of unmet needs for credible, proven strategies to 
manage body weight loss and meals. In an exploratory qualitative study, advanced cancer patients with 
prognosis of a few months were interviewed with their family members. The results revealed family 
members’ desire to maintain a nourishing role supported by professional advice on nutritio al care [37]. 
Another quantitative study showed that 73% of bereaved family members believed that advanced cancer 
patients treated at palliative care units require nutritional support. Furthermore, 41% of bereaved family 
members would like to have received sufficient explanations about the reasons for the patient’s body weight 
loss [19].  
 
In conclusion, eating-related distress in family members is multifaceted, comprising of themes of caregiver 
roles, attempts to fight back against the cancer, and caregiver mental health and well-being. Like patients, 
when family members fight back, many are disappointed by the futile attempts, which is compounded with 
lack of information, education as well as the perception of caregiver neglect of nutritional support. These 
experiences coalesce to generate and propagate family member’s eating-related distress (Table 1A). 
 
2.4. Conflicts over food between patients and family members 
Reduced food intake is frequently a source of conflict within families in palliative and supportive care 
settings [10-22]. Changes in patients' food preferences, changes in eating habits of whole families, 
challenges to spousal and family roles and traditions, family members' pressure on patients to eat, and 
differences in beliefs and perceptions between patients and family members can re ult in conflicts which 
worsen eating-related distress (Table 1A). A systematic review extracted “conflict with patient” as one of 
five themes of concern i  family members [17]. Patients often feel pressured to eat by family members, and 
distress may be generated when patients eat solely t  satisfy family members. This can make patients feel 
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dejected and harassed. As a result, patients may choose to isolate themselves or lie to family members to 
avoid such conflicts. Family members can experience feelings of rejection when food is refused, as well as, 
feelings of guilt when they argue with patients over patients’ lack of dietary intake [10-22]. Family members’ 
pressure may be applied unintentionally or due to a lack of insight into patient’s evolving cachexia, 
symptom burden, food preferences, and eating habits [10-22]. In summary, patients’ desire and ability to 
eat are sometimes incongruent with their family members’ expectations. Thus, contrary to family members’ 
intentions, their approach to diet and eating problems may become a barrier to increased food intake for 
patients, should the patient resist well-intentioned encouragement to eat [10-22]. 
 
Despite evidence offered by prior qualitative studies showing significant eating-related distr ss among 
patients and family members, quantitative studies suggest that overt conflicts over food between patients 
and family members occur less often than covert distress. In two earlier studies, the actual conflicts over 
food was reported in only 6-8% of patient and family members, whereas the perc ption of need for 
intervention in such conflicts was higher (18-2 %) [18,19]. In a more recent study, patients and family 
members quoted eating-related distress originating from interpersonal conflict to range between 50-60%. 
However, overt conflicts over food occurred much less frequently, at 20-30% [21]. Although the proportion 
who experience such conflicts may be small, the impact is big in the family. Unfortunately, because the 
quantitative studies were carried out for palliative care patients in one cultural setting, the observed 
dichotomy between overt conflicts and covert distress may not be applicable to other cultures and traditions, 
as well as, patients across varying stages of cancer cachexia. Further research is required to establish 
universality of this observation. 
 
3. Treatment approaches 
3.1. Role of palliative and supportive care 
Palliative and supportive care is usually considered as an all-encompassing servce pro iding care from 
cancer diagnosis to bereavement. The role of palliative and supportive care is for controlling symptoms and 
improving QOL for patients and their family members [38]. These services are invaluable to cancer patients 
as they are subjected to many nutrition impact symptoms, and potentially reversible causes of body weight 
loss. Some of these factors include intestinal motility disorders, esophageal/bowel obstruction, 
malabsorption, endocrine and metabolic disorders, and inability to sleep. Among them, pain (including 
oral pain due to mucositis), lack of appetite, early satiety, fatigue, drowsiness, nausea, vomiting, 
constipation, diarrhea, abnormal taste and smell, and difficulty swallowing may be particularly important 
[21-25, 28-32]. These symptoms need to be systematically assessed and treated, according to clinical 
practice guidelines, in order to minimize their impact on food intake. As evidence of this, a prospective trial 
in 2013 demonstrated that cancer patients receiving effective symptom management from a 
multidisciplinary palliative care service experienced concurrent improvement of appetite [39]. 
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Although palliative and supportive care advocate for holistic, multimodal care for cancer patients, several 
limitations exist within this field. Despite clinicians’ best efforts, up to 50% of patients with cancer have 
symptoms that have not been addressed [40]. Furthermore, eating-related distress has not been investigated 
in previous robust interventional studies. Once again, it is evident that a comprehensive assessment tool is 
needed to assess nutrition impact symptoms and related distress. Next, palliative and supportive care teams 
typically do not yet offer psychosocial interventions for cachexia-related distress. As such, communicative 
and educational interventions, tailored to patient’s prognosis and severity of cachexia, need to be developed 
[10-22]. These interventions may help patients and family members to cope with refractory cachexia, 
defined by the presence of rapidly progressive cancer unresponsive to anticancer therapy, and cachexia, 
characterized by intense catabolism and the presence of factors that render active management of body 
weight loss no longer possible or appropriate. End-of-life discussion and advanced care planning are an 
integral part of this conversation (Table 1B, 1C, Figure 1).  
 
3.2. Role of nutritional care 
Gaps in the availability or access to nutrition care is a major source of distress for patients and family 
members. Despite the best intentions, health care professionals may be unable to reliably identify the 
presence of insufficient dietary intake and implement active nutritional management [41]. Thus, evidence-
based clinical practice guidelines for nutritional care in the setting of advanced cancer are established to 
serve as health care professionals’ road maps for identification of malnutrition and the application of 
nutritional therapy. The 2017 European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines 
are of high quality based on their scope and purpose, rigor of development, applicability, and editorial 
independence [6, 42]. Specifically, the ESPEN strongly recommends: 1) Screening/monitoring for utrition 
risk in all patients with cancers of advanced stage, with in depth nutritional assessment for patients who 
screen positive. 2) Providing nutritional counselling and oral nutritional supplements as the 1st line approach, 
with escalation to artificial nutrition and hydration according to specified criteria.  
 
There is some evidence that body weight loss can be stabilized or even reversed to some degree by 
nutritional intervention. A 2017 prospective randomized controlled trial demonstrated that nutritional 
support resulted in a trend towards body weight gain in adult females with cancer ch xia [43]. A 2018 
retrospective study demonstrated that food, energy, and protein intake are associated with body weight gain 
in patients with advanced cancer referred to a multidisciplinary clinic for management of cachexia [44]. A 
2018 meta-analysis demonstrated that intake of high energy, high protein supplements enriched with n-3 
fatty acids resulted in body weight gain in patients undergoing chemotherapy or chemo-radiation with 
palliative intent [45]. In the very advanced cancer patients, only preliminary studies have shown t at 
nutritional support may be associated with beneficial effects, i.e., prevented bedsores, improved 
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performance status [46, 47]. 
 
The use of artificial nutrition is controversial for a variety of reasons. Patient and family members’ views 
on artificial nutrition are difficult to capture because views on artificial nutrition are often enmeshed with 
views on artificial hydration. It is also unclear whether patients and family members can distinguish 
between the two [20]. There are profound cultural and ethnic differences i  perceptions of artificial 
hydration during the last weeks of life [48]. For example, in Japan, a large study of the general public and 
bereaved family members showed that 33-50% of the respondents thought that artificial hydration should 
be continued until death [49]. In Germany, a survey of cancer patients revealed that 23% wished for both 
artificial nutrition and hydration at the end-of-life. Increasing age was significantly correlated with a 
decision to forgo artificial nutrition and hydration [50]. Finally, many patients and family members may 
attach significant meaning, hope and dignity to artificial hydration which substantially increases the 
difficulty of discontinuation of this treatment [51]. In summary, these studies suggest that the practice of 
artificial nutrition is complicated by perceptions and beliefs, cultural background, and age of patients.  
 
According to the ESPEN guideline on ethical aspects of artificial nutrition and hydration, decisions on 
artificial nutrition and hydration have to consider social, cultural, emotional, and existential aspects as well 
as the patients’ spiritual and ethnic background [52]. However, the ESPEN guidelines on nutrition in cancer 
patients also suggest that artificial nutrition and hydration are unlikely to provide any be efit for most 
patients in very advanced terminal phase [6]. Thus, initiation or discontinuation of artificial nutrition must 
be accompanied by acceptable explanation of benefits versus risk to patients and family members, while 
taking into account patients’ prognoses and goals of care. 
 
3.3. Integration of palliative, supportive, and nutritional care 
Multimodal care has been recommended as a treatment approach for advanced cancer patients with 
cachexia [4, 6, 53-56]. A systemic review demonstrated that multimodal rehabilitation program 
incorporating exercise and nutritional support improved many outcomes, e.g., improvements in physical 
endurance and depression, in patients with incurable cancer. Although the authors slightly described 
symptom management, there were no description about effects of management of nutrition impact 
symptoms on such outcomes [56]. Effective multimodal care is predicated on a seamless integration of 
symptom management, psychosocial support, nutritional support, and rehabilitation. There is relatively 
little research evaluating the efficacy of these combined interventions and their ability to simultaneously 
improve symptoms, distress, food intake, body weight, physical function, and QOL [39, 56-60]. The most 
encouraging data comes from clinical observational studies [39, 44]. In these studies, a team-based 
approach, involving palliative care physicians, nurses, dietitians, and occupational therapists, is associated 
with significant improvement in food intake, nutritional indices, distress, concurrent with successful 
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management of pain and symptoms. These results suggest that multimodal care needs to be managed by an 
interdisciplinary team consisting of specialists e.g., trained physicians, nurses, dietitians, pharmacists, and 
physical/occupational therapists.  
 
In spite of the merits of multimodal care in advanced cancer patients, several limitations are evident. Some 
patients with high symptom burden only achieved moderate improvement in their symptoms [39, 44]. 
Moreover, there often exists a gap between the ideal team environment and reality. Innovative local 
programs, such as a nurse-led walk-and-eat intervention, should not be discounted, as it could also improve 
patient outcomes, i.e., preserving functional walking capacity and nutritional status [61]. Finally, nutrition 
impact symptoms and eating-related distress are often not evaluated systematically. One recently developed 
instrument is the Quality of Life Questionnaire-Cachexia 24 (QLQ-CAX24), which offers a cachexia 
specific module for the assessment of QOL [62].  
 
Adapting from previous successes in multimodal care research, we would like to propose an integrated 
model of palliative, supportive, and nutritional care to alleviate eating-related distress (Table 1, Figure1). 
Our strategy is predicated on the adequate management of nutrition impact symptoms, psychosocial and 
nutritional support, provision of evidence-based information and advice, education about cancer cachexia, 
and initiation of end-of-life discussions. Anticipated outcomes from our integrated strategy include 
improvement in QOL, mitigation of conflicts, and promotion of advanced care planning among patients 
and family members by supporting for adaptation and coping with nutritional impact symptoms and eating-
related distress. Integral to the success of this strategy is the involvement and cooperation between 
oncologists, palliative care physicians, nurses, dietitians, and other healthcare professionals.  
 
4. Conclusions 
We summarized knowledge of eating-related distress in patients and family members and identified some 
potential priorities for future research. We found limited information about this important detriment to QOL 
for patients and family members, and there are effectively no well-developed educational tools or 
psychosocial interventions to alleviate this distress. There is a lack of validated tools for the clinical 
assessment of eating-related distress and its response to interventions. More robust evidence regarding 
breadth and depth of nutrition impact symptoms and their association with distress are needed. Palliative, 
supportive, and nutrition care have varying availability and in many contexts are implemented in isolation 
of one another. To inform and support patients and family members to cope effectively, h alth care 
professionals must appreciate the complexities and intricacies of eating-related distress. We propose that 
this will be facilitated by close coordination of palliative, supportive, and nutritional care. 
 
5. Limitations 
14 
 
The scope of the review was confined to caring for nutrition impact symptoms, eating-related distress, need 
for nutritional support, and conflicts over food among patients and family members. There might be studies 
on the other aspects of cancer cachexia and the management of symptoms and malnutrition during/after 
cancer treatments, which were not included. 
 
Acknowledgements 
The authors have read and complied with the principles of ethical authorship of t e j urnal. We would like 
to thank Dr Catherine Kubrak, Dr Lisa Martin, and Dr Zhimeng Jia for review and discussion of the 
manuscript. 
 
Conflict of interest 
The authors declare no potential conflicts of interest with respect to the research, authorship, and/or 
publication of this article. 
 
Funding 
The authors received no financial support for the research, authorship, and/or publication of this article. 
 
Contribution 
Study concept and design: KA and VB 
Data acquisition: KA, VB, and JH 
Data interpretation: KA, VB, and JH 
Manuscript preparation: KA, VB, and JH 
Manuscript editing and review: KA, VB, and JH 
 
  
15 
 
References 
1. Radbruch L, Elsner F, Trottenberg P, et al. Clinical practice guidelines on cancer cach xia in advanced 
cancer patients with a focus on refractory cachexia: European clinical guidelines. Aachen, Department 
of Palliative Medicine/European Palliative Care Research Collaborative 2010. 
2. Fearon KC, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an 
international consensus. Lancet Oncol 2011; 12: 489– 95. 
3. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89: 381–410. 
4. Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer 
cachexia. Nat Rev Clin Oncol 2013; 10(2): 90-99. 
5. Amano k, Maeda I, Morita T, et al. Clinical implications of C-reactive protein as a prognostic marker 
in advanced cancer patients in palliative settings. J Pain Symptom Manage 2016; 51(5): 860-867. 
6. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin 
Nutr 2017; 36: 11-48. 
7. Amano K, Maeda I, Morita T, et al. C-reactive protein, symptoms and activity of daily living in 
patients with advanced cancer receiving palliative care. J Cachexia Sarcopenia Muscle 2017; 8: 457-
465. 
8. Baracos VE, Martin L, Korc M, et al. Cancer-associated cachexia. Nat Rev Dis Primers 2018. doi: 
10.1038/nrdp.2017.105. 
9. Sadeghi M, Keshavarz-Fathi M, Baracos V, et al. Cancer cachexia: Diagnosis, assessment, and 
treatment. Crit Rev Oncol Hematol 2018; 127: 91-104. 
10. Strasser F, Binswanger J, Cemy T, et al. Fighting a losing battle: eating related distrss of men with 
advanced cancer and their female partners: a mixed methods study. Palliat Med 2007; 21(2): 129–137. 
11. Hopkinson JB, Okamoto I, Addington-Hall JM. What to eat when off treatment and living with 
involuntary weight loss and cancer: a systematic search and narrative review. Support Care Cancer 
2011; 19(1): 1-17. 
12. Oberholzer R, Hopkinson JB, Baumann K, et al. Psychosocial effects of cancer cachexia: A systematic 
literature search and qualitative analysis. J Pain Symptom Manage 2013; 46(1): 77-95. 
13. Hopkinson JB. Psychosocial impact of cancer cachexia. J Cachexia Sarcopenia Muscle 2014; 5: 89-
94. 
14. Reid J. Psychosocial, educational and communicative interventions for patients with cachexia and 
their family carers. Curr Opin Support Palliat Care 2014; 8( ): 334–338. 
15. Cooper C, Burden ST, Cheng H, Molassiotis A. Understanding and managing cancer-related weight 
loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia 
Muscle 2015; 6(1): 99-111. 
16. Hopkinson, JB. Food connections: A qualitative exploratory study of weight- and eating-related 
distress in families affected by advanced cancer. Eur J Oncol Nurs 2016; 20: 87-96. 
16 
 
17. Wheelwright S, Darlington AS, Hopkinson JB, et al. A systematic review and thematic synthe is of 
quality of life in the informal carers of cancer patients with cachexia. Palliat Med 2016; 3 (2): 149-
160. 
18. Amano K, Maeda I, Morita T, et al. Need for nutritional support, eating-related distress and experience 
of terminally ill cancer patients: A survey in an inpatient hospice. BMJ Support Palliat Care 2016; 6 
(3): 373-376. 
19. Amano K, Maeda I, Morita T, et al. Eating-related distress and need for nutritional support of families 
of advanced cancer patients: a nationwide survey of bereaved family members. J Cachexia Sarcopenia 
Muscle 2016; 7 (5): 527-534. 
20. Amano K, Morita T, Miyamoto J, et al. Perception of need for nutritional support in advanced cancer 
patients with cachexia: a survey in palliative care settings. Support Care Cancer 2018; 26(8): 2793-
2799. 
21. Amano K, Morita T, Koshimoto S, et al. Eating-related distress in advanced cancer patients 
with cachexia and family members: a survey in palliative and supportive care settings. Support Care 
Cancer 2018; Dec 15. doi: 10.1007/s00520-018-4590-6. 
22. Koshimoto S, Arimoto M, Saitou K, et al. Need and demand for nutritional counselling and their 
association with quality of life, nutritional status and eating-related distress among patients with 
cancer receiving outpatient chemotherapy: a cross-sectional study. Support Care Cancer 2019; Jan 14. 
doi: 10.1007/s00520-018-4628-9. 
23. Kubrak C, Olson K, Jha N, et al. Nutrition impact symptoms: key determinants of reduced dietary 
intake, weight loss, and reduced functional capacity of patients with head and neck cancer before 
treatment. Head Neck 2010; 32(3): 290-300. 
24. Anandavadivelan P, Martin L, Djärv T, et al. Nutrition Impact Symptoms Are Prognostic of Quality 
of Life and Mortality after Surgery for Oesophageal Cancer. Cancers (Basel). 2018 Sep 7;10(9). pii: 
E318. doi:10.3390/cancers10090318. 
25. Martin L, Kubrak C. How much does reduced food intake contribute to cancer-associated weight loss? 
Curr Opin Support Palliat Care 2018; 12(4): 410-419. 
26. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton symptom assessment system (ESAS): a simple 
method for the assessment of palliative care patients. J Palliat Care 1991; 7: 6-9. 
27. Bauer J, Capra S, Ferguson M. Use of the scored patient generated subjective global assessment (PG-
SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56(8): 779-785. 
28. Del Fabbro E, Orr TA, Stella SM. Practical approaches to managing cancer patients with weight loss. 
Curr Opin Support Palliat Care 2017; 11(4): 272-277. 
29. Kubrak C, Olson K, Baracos VE. The head and neck symptom checklist©: an instrument to evaluate 
nutrition impact symptoms effect on energy intake and weight loss. Support Care Cancer 2013; 21(11): 
3127-3136. 
17 
 
30. Del Fabbro E, Hui D, Dalal S, et al. Clinical outcomes and contributors to weight loss in a cancer 
cachexia clinic. J Palliat Med 2011; 14(9): 1004-1008. 
31. Omlin A, Blum D, Wierecky J, et al. Nutrition impact symptoms in advanced cancer patients: 
frequency and specific interventions, a case-control study. J Cachexia Sarcopenia Muscle 2013; 4(1): 
55-61. 
32. Blum D, Stene GB, Solheim TS, et al. Validation of the consensus-definition for Cancer Cachexia and 
evaluation of a classification model–a study based on data from an international multicentre project 
(EPCRC-CSA). Ann Oncol 2014; 25(8): 1635-1642. 
33. Calman KC. Quality of life in cancer patients – a hypothesis. J Med Ethics 1984; 10(3): 124-127. 
34. McClemen SE, Degner LF, Harlos MS. Family beliefs regarding the nutritional care of a t rminally 
ill relative: a qualitative study. J Palliat Med 2003; 6(5): 737-48. 
35. McClement SE, Degner LF, Harlos M. Family responses to declining intake and weight loss in a 
terminally ill relative. Part 1: fighting back. J Palliat Care 2004; 20(2): 93-100. 
36. McClement SE, Harlos M. When advanced cancer patients won’t eat: family responses. Int J Palliat 
Nurs 2008; 14(4): 182-188. 
37. Hopkinson JB. The Nourishing Role: Exploratory Qualitative Research Revealing Unmet Support 
Needs in Family Carers of Patients With Advanced Cancer and Eating Problems. Cancer Nurs 2018; 
41(2): 131-138. 
38. Hui D, De La Cruz M, Mori M, et al. Concepts and definitions for “supportive care,” “best supportive          
care,” “palliative care,” and “hospice care” in the published literature, dictionaries, and textbooks. 
Support Care Cancer 2013; 21(3): 659-685. 
39. Gagnon B, Murphy J, Eades M, et al. A prospective evaluation of an interdisciplinary nutrition-
rehabilitation program for patients with advanced cancer. Curr Oncol 2013; 20(6): 310-318. 
40. Basch E. Missing Patients' Symptoms in Cancer Care Delivery--The Importance of Patient-Reported     
Outcomes. JAMA Oncol 2016; 2(4): 433-434. 
41. Hébuterne X, Lemarié E, Michallet M, et al. Prevalence of malnutrition and current use of nutrition 
support in patients with cancer. JPEN J Parenter Enteral Nutr 2014; 38(2): 196-204. 
42. Shen WQ, Yao L, Wang XQ, et al. Quality assessment of cancer cachexia clinical practice guidelines. 
Cancer Treat Rev 2018; 70: 9-15.  
43. Kapoor N, Naufahu J, Tewfik S, et al. A prospective randomized controlled trial to study the impact 
of a nutrition-sensitive intervention on adult women with cancer cachexia undergoing palliative care 
in India. Integr Cancer Ther 2017; 16: 74-8 . 
44. Nasrah R, Kanbalian M, Van Der Borch C, et al. Defining the role of dietary intake in determining 
weight change in patients with cancer cachexia. Clin Nutr 2018; 37: 235-241. 
45. de van der Schueren MAE, Laviano A, Blanchard H, et al. Systematic review and meta-analysis of the 
evidence for oral nutritional intervention on nutritional and clinical outcomes during 
18 
 
chemo(radio)therapy: current evidence and guidance for design of future trials. Ann Oncol 2018; 
29(5): 1141-1153. 
46. Amano K, Morita T, Baba M et al. Effect of nutritional support on terminally ill patients with cancer 
in a palliative care unit. Am J Hosp Palliat Care 2013; 30(7): 728-731. 
47. Amano K, Maeda I, Ishiki H et al. A feasibility study to investigate the effect of nutritional support 
for advanced cancer patients in an inpatient hospice in Japan. Palliat Med Hosp Care Open J 2016; 
2(2): 37-45. 
48. Torres-Vigil I, Cohen MZ, de la Rosa A, et al. Food or medicine: ethnic variations in perceptions of 
advanced cancer patients and their caregivers regarding artificial hydration during the last weeks of 
life. BMJ Support Palliat Care 2012; 2(3): 276-279. 
49. Morita T, Miyashita M, Shibagaki M, et al. Knowledge and beliefs about end-of-life care and the 
effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage 
2006; 31(4): 306-316. 
50. Bükki J, Unterpaul T, Nübling G, et al. Decision making at the end of life—cancer patients’ and their 
caregivers’ views on artificial nutrition and hydration. Support Care Cancer 2014; 22(12): 3287-399. 
51. Cohen MZ, Torres-Vigil I, Burbach BE, et al. The meaning of parenteral hydration to family 
caregivers and patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2012; 
43(5): 855-865. 
52. Druml C, Ballmer PE, Druml W, et al. ESPEN guideline on ethical aspects of artificial nutritio  and 
hydration. Clin Nutr 2016; 35: 545-556. 
53. Aapro M, Arends J, Bozzetti F, et al., ESMO (European School of Medical Oncology). Early 
recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School 
of Oncology Task Force. Ann Oncol 2014; 25(8): 1492-1499. 
54. Balstad TR, Kaasa S, Solheim TS. Multimodal nutrition/anabolic therapy for wasting conditions. Curr 
Opin Clin Nutr Metab Care 2014; 17(3): 226-235. 
55. Maddocks M, Hopkinson J, Conibear J, et al. Practical multimodal care for cancer cachexia. Curr 
Opin Support Palliat Care 2016; 10(4): 298-305. 
56. Hall CC, Cook J, Maddocks M, et al. Combined exercise and nutritional rehabilitation in outpatients 
with incurable cancer: a systematic review.Support Care Cancer 2019; 27(7): 2371-2384. 
57. Glare P, Jongs W, Zafiropoulos B. Establishing a cancer nutrition rehabilitation program (CNRP) for 
ambulatory patients attending an Australian cancer center. Support Care Cancer 2011; 19(4): 445-454. 
58. Parmar MP, Swanson T, Jagoe RT. Weight changes correlate with alterations in subjective physical 
function in advanced cancer patients referred to a specialized nutrition and rehabilitation team. 
Support Care Cancer 2013; 21(7): 2049-2057. 
59. Parmar MP, Vanderbyl BL, Kanbalian M, et al. A multidisciplinary rehabilitation programme for 
cancer cachexia improves quality of life. BMJ Support Palliat Care 2017; 7(4): 441-449. 
19 
 
60. Uster A, Ruehlin M, Mey S, et al. Effects of nutrition and physical exercise intervention in palliative 
cancer patients: a randomized controlled trial. Clin Nutr 2018; 37(4): 1202-1209. 
61. Xu YJ, Cheng JC, Lee JM, et al. A walk-and-eat intervention improves outcomes for patients with 
esophageal cancer undergoing neoadjuvant chemoradiotherapy. Oncologist 2015; 20(10): 1216-1222. 
62. Wheelwright SJ, Hopkinson JB, Darlington AS, et al. Development of the EORTC QLQ-CAX24, A 
Questionnaire for Cancer Patients with Cachexia. J Pain Symptom Manage 2017; 53(2): 232-242.  
 
